Evidence map›Paper›PMID 39760242›Full record

ArticleCancer control : journal of the Moffitt Cancer Center

Tumor Mutation Signature Reveals the Risk Factors of Lung Adenocarcinoma with

Jialiang Wang, Chang Guo, Jiexiao Wang, Xiaopeng Zhang, Jian Qi, Xiang Huang, Zongtao Hu, Hongzhi Wang, Bo Hong

Abstract read
In one paragraph

Article in Cancer control : journal of the Moffitt Cancer Center. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jialiang WangSchool of Basic Medical Sciences, Anhui Medical University, Hefei, China.
Chang GuoSchool of Basic Medical Sciences, Anhui Medical University, Hefei, China.
Jiexiao WangSchool of Basic Medical Sciences, Anhui Medical University, Hefei, China.
Xiaopeng ZhangHefei Cancer Hospital of CAS, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences (CAS), Hefei, China.
Jian QiHefei Cancer Hospital of CAS, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences (CAS), Hefei, China.
Xiang HuangHefei Cancer Hospital of CAS, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences (CAS), Hefei, China.
Zongtao HuHefei Cancer Hospital of CAS, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences (CAS), Hefei, China.
Hongzhi WangSchool of Basic Medical Sciences, Anhui Medical University, Hefei, China.
Bo HongSchool of Basic Medical Sciences, Anhui Medical University, Hefei, China.ORCID 0000-0001-8117-5029

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introduction

methodsThis was a retrospective study. TMS of LUAD with

resultsIn LUAD with

conclusionsTMS analysis reveals that smoking is associated with LUAD with

Indexed as

Adenocarcinoma of LungErbB ReceptorsLung NeoplasmsMutationProto-Oncogene Proteins p21(ras)AgedFemaleHumansMaleMiddle AgedRetrospective StudiesRisk FactorsSmokingEGFR protein, humanErbB ReceptorsKRAS protein, humanProto-Oncogene Proteins p21(ras)EGFR mutationKRAS mutationlung adenocarcinomarisk factortumor mutational signature

Identifiers

PMID39760242
PMCPMC11701915

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.